Tricuspid Valve Replacement by Made to Measure ProxiCor® Extracellular Matrix Valve (Elutia, US)

Primary tricuspid regurgitation due to infective endocarditis in young patients with a history of intravenous substance abuse represents a dilemma in terms of prosthesis selection if reconstruction is not a feasible option.We present a novel approach for tricuspid valve replacement in adults by a customized intraoperatively assembled neo-valve using the Elutia (US) Proxicor Extracellular Matrix (ECM).